Rudolph Navari to Follow-Up Studies
This is a "connection" page, showing publications Rudolph Navari has written about Follow-Up Studies.
Connection Strength
0.073
-
Symptomatic treatment of infections in patients with advanced cancer receiving hospice care. J Pain Symptom Manage. 2005 Aug; 30(2):175-82.
Score: 0.040
-
Phase III safety study of intravenous NEPA: a novel fixed antiemetic combination of fosnetupitant and palonosetron in patients receiving highly emetogenic chemotherapy. Ann Oncol. 2018 07 01; 29(7):1535-1540.
Score: 0.025
-
Efficacy and safety of different doses of granisetron for the prophylaxis of cisplatin-induced emesis. Support Care Cancer. 1997 Jan; 5(1):31-7.
Score: 0.006
-
Treatment of marrow graft recipients with thymopentin. Bone Marrow Transplant. 1987 Apr; 1(4):365-71.
Score: 0.003